1. Newsroom
  2. Oil market review
Menu
Analysen 28.02.2019

Oil market review

Oil market review

Oil prices are up more than 23% year to date, with WTI increasing by more than USD 11 in under two months, reaching USD 56 towards the end of February.


  • The rally came as investors gauged OPEC’s effectiveness at keeping their promise to trim production by 1.2 mbd (using October’s numbers as a benchmark).
  • While the announcement was met with a lot of scepticism at the time, OPEC supply numbers according to Bloomberg showed a 1.5 mbd decrease between December and January, triggering the strong WTI rally and proving OPEC’s ability to deliver on their promises. So far, the implementation of the recent cuts is mirroring those cuts announced in November 2016 and implemented in 2017, when oil prices increased by more than 30%. It is clear that OPEC and its allies are trying to alleviate the downside pressure on crude prices by tightening supply while avoiding a market shortage. OPEC also has to manage President Donald Trump’s efforts to control prices.
  • It is important to note, however, that a portion of the production decrease by OPEC was unplanned, with an unintended 400,000 barrel decline in production on the part of Iran, Libya, Nigeria and Venezuela. Looking at Venezuela, despite its relatively low output and despite the world’s demand for heavy oil, the country is being forced to reduce production, as buyers are reluctant to take its “US-sanctioned” oil.
  • While investors have been focusing more on the possibility of supply tightening, the sensitivity of oil prices to global demand remains high and the threat of a slowdown in Chinese oil demand, coupled with the uncertainty surrounding the China–US trade war, should continue to fuel volatility on the commodity. Even though Trump recently announced substantial progress in trade talks, he might draw out any resolution of the issue, preventing a drop in price volatility.
  • Looking at oil companies, despite the fact that Q4 is historically the worst-performing quarter for the energy sector, Q4 2018 results were quite different, with most companies beating expectations on major key figures. European supermajors – our preferred subsector – showed strong cash generation and solid de-gearing of balance sheets, while maintaining strong positive momentum on dividend growth and share buybacks. Cash flow generation, CAPEX control and dividend growth should continue to be the dominant themes for European supermajors in 2019.
Investment expertise

Melki_Pierre_150x150.jpg

Pierre Melki
Equity Analyst Advisory Services

Expertise

Diskretionäres Portfolio-management: Sie haben die Zügel in der Hand

Ihre Ziele und Wünsche sind einzigartig – genauso wie unser Ansatz im diskretionären Portfoliomanagement
Mehr
Expertise

Swiss & Global Equities

Why Swiss equities now? This market offers equity investors the stability and agility they need to navigate this volatile period. 

Read more
Expertise

European Equities

European equities offer unrivalled opportunities in terms of breadth of sector and market exposure.

Read more

Meistgelesene News

Analysen 10.02.2021

COVID-19: Die UBP hält Sie auf dem Laufenden

Seit dem Ausbruch des Coronavirus begleiten und unterstützen wir unsere Kunden während dieser ungewöhnlichen Zeit einer weltweiten Gesundheitskrise. Die Bank informiert Sie regelmässig über die Anpassungen ihrer Massnahmen an die von den Gesundheitsbehörden vorgegebenen Vorsichtsregeln. Ausserdem kommen unsere Experten zu Wort, welche auf die Auswirkungen der Pandemie auf die Weltwirtschaft und die Finanzmärkte eingehen.

Analysen 17.12.2020

UBP Investment Outlook 2021

Schöne neue Welt

Analysen 24.11.2020

Perlen im SMID-Cap-Segment in Europa und der Schweiz

Unternehmen kleiner und mittlerer Kapitalisierung verzeichnen oftmals höhere Wachstumsraten und Renditen als Grosskonzerne. Es ist einfacher, ein kräftiges Wachstum von einer kleineren Basis aus zu generieren. Die sogenannten SMID Caps bieten Anlegern eine Positionierung in langfristigen Wachstumstrends.


Auch lesenswert

Analysen 14.04.2021

The vaccine disrupting the pharma industry

UBP talks to Stéphane Bancel, Moderna CEO, to learn how the mRNA technology not only made one of the first COVID-19 vaccines possible, but, more importantly for investors, has the potential to disrupt the broader pharmaceutical industry in its wake.

Analysen 05.04.2021

Transitioning to a Brave New World

Volatility is back in Chinese equity markets: after rallying 90% from its trough in March 2020 to a peak in February 2021, MSCI China has fallen by 16% over the past month.

Analysen 24.03.2021

Diskretionäres Portfolio-management: Sie haben die Zügel in der Hand

Ihre Ziele und Wünsche sind einzigartig – genauso wie unser Ansatz im diskretionären Portfoliomanagement